Table 3 General information of patients included in the study
From: PSMC2 is overexpressed in glioma and promotes proliferation and anti-apoptosis of glioma cells
| Â | Control group (n = 30) | Glioma patients group (n = 30) | |
|---|---|---|---|
Age (years) | 39~73 (56) | 22~69 (47) | |
Gender (Male/Female) | 17/13 | 17/13 | |
WHO Central Nervous System Tumor Classification | Grade I | Â | 5 |
Grade II | Â | 8 | |
Grade III | Â | 7 | |
Grade IV | Â | 10 | |
Diameter of the tumor (mm) | Â | 46.12 (7.12) | |